KCT0004860招募中未知
Appropriate Duration of Anti-Platelet and Thrombotic strategy after 12 months in patients with Atrial Fibrillation treated with Drug Eluting Stents
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 960
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 85(Year)（—）
- 性别
- All
入选标准
- •1. Over 19 years old
- •2. Patient who underwent PCI with DES 12 months to 18 months ago
- •3. Non-valvular atrial fibrillation patients requiring long-term anticoagulation
排除标准
- •1. Over 85 years old
- •2. Pregnancy or Potential Pregnancy
- •3. Life expectancy within 1 year
- •4. Patients who refuse or do not understand the written consent form
- •5. Requiring anticoagulation due to history of mechanical valve replacement, mitral stenosis or deep vein thrombosis
- •6. Coagulopathy, continuous bleeidng, or Hb level below 10 g/dL
- •7. Intracerebral hemorrhage within 2 months
- •8. Patients with gastrointestinal hemorrhage within three months of registration
- •9. Patients diagnosed with a gastrointestinal tumor that requires continuous treatment
研究者
相似试验
招募中
不适用
Appropriate Duration of Anti-Platelet straTegy in patients with advance Chronic Kideny Disease after new generation drug eluting stents (ADAPT-CKD)KCT0005775Yonsei University Health System, Severance Hospital900
已完成
不适用
ShorT and OPtimal duration of Dual AntiPlatelet Therapy studycoronary artery diseaseJPRN-UMIN000008878Kyoto University Hospital1,500
进行中（未招募）
4 期
ShorT and OPtimal duration of Dual AntiPlatelet Therapy-3 studyIschemic heart disease, stable angina, myocardial infarctionJPRN-jRCTs052200114Ono Koh6,000
进行中（未招募）
4 期
ShorT and OPtimal duration of Dual AntiPlatelet Therapy-2 study for patients with ACSJPRN-jRCTs052180193Ono Koh3,000
进行中（未招募）
不适用
Optimal duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms: A prospective randomized multicenter trialDiseases of the circulatory systemKCT0006651Seoul National University Bundang Hospital528